Garenoxacin

DB06160ExperimentalSmall molecule

Garenoxacin, a quinolone antibiotic, is being investigated for the treatment of gram-positive and gram-negative bacterial infections.

Chemical structure of Garenoxacin
Primary indication
Investigated for use/treatment in bacterial infection.Curator reviewed
Formula / weight
C23H20F2N2O4 · 426.42 g/mol (avg)
Code names
BMS-284756 · T-3811

Resolves to

Compound
UNIIV72H9867WBCAS194804-75-6ChEMBLCHEMBL215303ChEBI131716
Clinical / RWD
ATCJ01MA19
Structure
InChIKeyNJDRXTDGYFKORP-LLVKDONJSA-NSMILESC[C@H]1NCC2=CC(=CC=C12)C1=CC=C2C(=O)C(=CN(C3CC3)C2=C1OC(F)F)C(O)=O
Targets
Q02880TOP2BP11388TOP2A

What you can answer from here — as of September 13, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
963Drug interactionsStructured to mechanism, not free text
Sign in
1ATC codeIncluding every combination product, plus 18 drug categories
Sign in
5+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Garenoxacin, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In